nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

18.05.2023 | Basic Science

Park7 protects retinal ganglion cells and promotes functional preservation after optic nerve crush via regulation of the Nrf2 signaling pathway

verfasst von: Lingyi Ouyang, Tao He, Yiqiao Xing

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aim to investigate the effect of Park7 on mice RGC survival and function following optic nerve crush (ONC), and to explore its potential mechanism.

Methods

Wild-type male C57BL/6J mice were subjected to optic nerve crush. Six weeks before ONC, mice received rAAV-shRNA (Park7)-EGFP or rAAV-EGFP intravitreally. Western blotting was used to detect Park7 levels. RGC survival was measured using immunofluorescence. Retinal cell apoptosis was detected using terminal deoxynucleotidyl transferase nick-end-labelling. An electroretinogram (ERG) and the optomotor response (OMR) were used to assess RGC function. Kelch-like ECH-associated protein 1 (Keap1), nuclear factor erythroid 2-related factor (Nrf2), and heme oxygenase 1 (HO-1) levels were assessed using western blotting.

Results

ONC injury increased the relative expression of Park7 significantly and decreased RGC survival, the amplitude of the photopic negative response (PhNR), and OMR. Intravitreal injection of rAAV-shRNA(Park7)-EGFP downregulated Park7 expression and was clearly demonstrated by the green fluorescence protein in many retinal layers. Moreover, Park7 downregulation aggravated the decrease in RGC survival and amplitude of PhNR as well as the visual acuity after ONC. However, inhibition of Park7 significantly increased Keap1 levels, decreased the total and nuclear Nrf2 levels, and reduced HO-1 levels.

Conclusions

Park7 downregulation enhanced RGC injury and decreased retinal electrophysiological response and OMR after ONC in mice via the Keap1-Nrf2-HO-1 signaling pathway. Park7 may have neuroprotective effects and could represent a novel way to treat optic neuropathy.

Baden T, Berens P, Franke K, Roman RM, Bethge M, Euler T (2016) The functional diversity of retinal ganglion cells in the mouse. Nature 529:345–350. https://doi.org/10.1038/nature16468CrossRefPubMedPubMedCentral

Sanes JR, Masland RH (2015) The types of retinal ganglion cells: current status and implications for neuronal classification. Annu Rev Neurosci 38:221–246. https://doi.org/10.1146/annurev-neuro-071714-034120CrossRefPubMed

Almasieh M, Wilson AM, Morquette B, Cueva VJ, Di Polo A (2012) The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 31:152–181. https://doi.org/10.1016/j.preteyeres.2011.11.002CrossRefPubMed

Mohan K, Kecova H, Hernandez-Merino E, Kardon RH, Harper MM (2013) Retinal ganglion cell damage in an experimental rodent model of blast-mediated traumatic brain injury. Invest Ophthalmol Vis Sci 54:3440–3450. https://doi.org/10.1167/iovs.12-11522CrossRefPubMedPubMedCentral

Tang Z, Zhang S, Lee C, Kumar A, Arjunan P, Li Y, Zhang F, Li X (2011) An optic nerve crush injury murine model to study retinal ganglion cell survival. Jove-J Vis Exp. https://doi.org/10.3791/2685CrossRef

Schwartz M (2004) Optic nerve crush: protection and regeneration. Brain Res Bull 62:467–471. https://doi.org/10.1016/S0361-9230(03)00076-5CrossRefPubMed

Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256–259. https://doi.org/10.1126/science.1077209CrossRefPubMed

Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, Brice A, van Duijn CM, Oostra B, Meco G, Heutink P (2003) DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24:159–160. https://doi.org/10.1007/s10072-003-0108-0CrossRefPubMed

Antipova D, Bandopadhyay R (2017) Expression of DJ-1 in neurodegenerative disorders. Adv Exp Med Biol 1037:25–43. https://doi.org/10.1007/978-981-10-6583-5_3CrossRefPubMed

10.

Buneeva OA, Medvedev AE (2021) DJ-1 protein and its role in the development of Parkinson’s disease: studies on experimental models. Biochem-Moscow+ 86:627–640. https://doi.org/10.1134/S000629792106002XCrossRef

11.

Huang M, Chen S (2021) DJ-1 in neurodegenerative diseases: pathogenesis and clinical application. Prog Neurobiol 204:102114. https://doi.org/10.1016/j.pneurobio.2021.102114CrossRefPubMed

12.

Biosa A, Sandrelli F, Beltramini M, Greggio E, Bubacco L, Bisaglia M (2017) Recent findings on the physiological function of DJ-1: beyond Parkinson’s disease. Neurobiol Dis 108:65–72. https://doi.org/10.1016/j.nbd.2017.08.005CrossRefPubMed

13.

Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY (2019) Role of DJ-1 in the mechanism of pathogenesis of Parkinson’s disease. J Bioenerg Biomembr 51:175–188. https://doi.org/10.1007/s10863-019-09798-4CrossRefPubMedPubMedCentral

14.

Repici M, Giorgini F (2019) DJ-1 in Parkinson’s disease: clinical insights and therapeutic perspectives. J Clin Med 8. https://doi.org/10.3390/jcm8091377

15.

Cheng L, Zhang W (2021) DJ-1 affects oxidative stress and pyroptosis in hippocampal neurons of Alzheimer’s disease mouse model by regulating the Nrf2 pathway. Exp Ther Med 21:557. https://doi.org/10.3892/etm.2021.9989CrossRefPubMedPubMedCentral

16.

Wang T, Zhao N, Peng L, Li Y, Huang X, Zhu J, Chen Y, Yu S, Zhao Y (2020) DJ-1 regulates microglial polarization through P62-mediated TRAF6/IRF5 signaling in cerebral ischemia-reperfusion. Front Cell Dev Biol 8:593890. https://doi.org/10.3389/fcell.2020.593890CrossRefPubMedPubMedCentral

17.

Martin-Nieto J, Uribe ML, Esteve-Rudd J, Herrero MT, Campello L (2019) A role for DJ-1 against oxidative stress in the mammalian retina. Neurosci Lett 708:134361. https://doi.org/10.1016/j.neulet.2019.134361CrossRefPubMed

18.

Cameron EG, Xia X, Galvao J, Ashouri M, Kapiloff MS, Goldberg JL (2020) Optic nerve crush in mice to study retinal ganglion cell survival and regeneration. Bio-Protocol 10. https://doi.org/10.21769/BioProtoc.3559

19.

Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Nieto-Lopez L, Canovas-Martinez I, Salinas-Navarro M, Vidal-Sanz M, Agudo M (2009) Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophth Vis Sci 50:3860–3868. https://doi.org/10.1167/iovs.08-3267CrossRef

20.

Mead B, Tomarev S (2016) Evaluating retinal ganglion cell loss and dysfunction. Exp Eye Res 151:96–106. https://doi.org/10.1016/j.exer.2016.08.006CrossRefPubMedPubMedCentral

21.

Kretschmer F, Sajgo S, Kretschmer V, Badea TC (2015) A system to measure the optokinetic and optomotor response in mice. J Neurosci Meth 256:91–105. https://doi.org/10.1016/j.jneumeth.2015.08.007CrossRef

22.

Neves M, Graos M, Anjo SI, Manadas B (2022) Modulation of signaling pathways by DJ-1: an updated overview. Redox Biol 51:102283. https://doi.org/10.1016/j.redox.2022.102283CrossRefPubMedPubMedCentral

23.

Saito Y (2017) DJ-1 as a biomarker of Parkinson’s disease. Adv Exp Med Biol 1037:149–171. https://doi.org/10.1007/978-981-10-6583-5_10CrossRefPubMed

24.

Shimizu Y, Lambert JP, Nicholson CK, Kim JJ, Wolfson DW, Cho HC, Husain A, Naqvi N, Chin LS, Li L, Calvert JW (2016) DJ-1 protects the heart against ischemia-reperfusion injury by regulating mitochondrial fission. J Mol Cell Cardiol 97:56–66. https://doi.org/10.1016/j.yjmcc.2016.04.008CrossRefPubMedPubMedCentral

25.

Yang RX, Lei J, Wang BD, Feng DY, Huang L, Li YQ, Li T, Zhu G, Li C, Lu FF, Nie TJ, Gao GD, Gao L (2017) Pretreatment with sodium phenylbutyrate alleviates cerebral ischemia/reperfusion injury by upregulating DJ-1 protein. Front Neurol 8:256. https://doi.org/10.3389/fneur.2017.00256CrossRefPubMedPubMedCentral

26.

Ruan Y, Jiang S, Gericke A (2021) Age-related macular degeneration: role of oxidative stress and blood vessels. Int J Mol Sci 22. https://doi.org/10.3390/ijms22031296

27.

Kang Q, Yang C (2020) Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol 37:101799. https://doi.org/10.1016/j.redox.2020.101799CrossRefPubMedPubMedCentral

28.

Pinazo-Duran MD, Zanon-Moreno V, Gallego-Pinazo R, Garcia-Medina JJ (2015) Oxidative stress and mitochondrial failure in the pathogenesis of glaucoma neurodegeneration. Prog Brain Res 220:127–153. https://doi.org/10.1016/bs.pbr.2015.06.001CrossRefPubMed

29.

Bonilha VL, Bell BA, Rayborn ME, Yang X, Kaul C, Grossman GH, Samuels IS, Hollyfield JG, Xie C, Cai H, Shadrach KG (2015) Loss of DJ-1 elicits retinal abnormalities, visual dysfunction, and increased oxidative stress in mice. Exp Eye Res 139:22–36. https://doi.org/10.1016/j.exer.2015.07.014CrossRefPubMedPubMedCentral

30.

Bonilha VL, Rayborn ME, Yang X, Xie C, Cai H (2014) Oxidative stress regulation by DJ-1 in the retinal pigment epithelium. Adv Exp Med Biol 801:649–654. https://doi.org/10.1007/978-1-4614-3209-8_81CrossRefPubMedPubMedCentral

31.

Gharbi N, Roise D, Forre JE, Edson AJ, Hushagen HA, Tronci V, Froyset AK, Fladmark KE (2021) Reintroduction of DJ-1 in Muller cells inhibits retinal degeneration in the DJ-1 deficient retina. Antioxidants-Basel 10. https://doi.org/10.3390/antiox10121862

32.

Wang W, Zhao H, Chen B (2020) DJ-1 protects retinal pericytes against high glucose-induced oxidative stress through the Nrf2 signaling pathway. Sci Rep-UK 10:2477. https://doi.org/10.1038/s41598-020-59408-2CrossRef

33.

Zeng J, Zhao H, Chen B (2019) DJ-1/PARK7 inhibits high glucose-induced oxidative stress to prevent retinal pericyte apoptosis via the PI3K/AKT/mTOR signaling pathway. Exp Eye Res 189:107830. https://doi.org/10.1016/j.exer.2019.107830CrossRefPubMed

34.

Almikhlafi MA, Stauch KL, Villeneuve LM, Purnell PR, Lamberty BG, Fox HS (2020) Deletion of DJ-1 in rats affects protein abundance and mitochondrial function at the synapse. Sci Rep-UK 10:13719. https://doi.org/10.1038/s41598-020-70486-0CrossRef

35.

Chen R, Park HA, Mnatsakanyan N, Niu Y, Licznerski P, Wu J, Miranda P, Graham M, Tang J, Boon A, Cossu G, Mandemakers W, Bonifati V, Smith P, Alavian KN, Jonas EA (2019) Parkinson’s disease protein DJ-1 regulates ATP synthase protein components to increase neuronal process outgrowth. Cell Death Dis 10:469. https://doi.org/10.1038/s41419-019-1679-xCrossRefPubMedPubMedCentral

36.

Chrysostomou V, Crowston JG (2013) The photopic negative response of the mouse electroretinogram: reduction by acute elevation of intraocular pressure. Invest Ophth Vis Sci 54:4691–4697. https://doi.org/10.1167/iovs.13-12415CrossRef

37.

Marmoy OR, Viswanathan S (2021) Clinical electrophysiology of the optic nerve and retinal ganglion cells. Eye 35:2386–2405. https://doi.org/10.1038/s41433-021-01614-xCrossRefPubMedPubMedCentral

38.

Viswanathan S, Frishman LJ, Robson JG, Harwerth RS, Smith ER (1999) The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma. Invest Ophth Vis Sci 40:1124–1136

39.

Kretschmer F, Tariq M, Chatila W, Wu B, Badea TC (2017) Comparison of optomotor and optokinetic reflexes in mice. J Neurophysiol 118:300–316. https://doi.org/10.1152/jn.00055.2017CrossRefPubMedPubMedCentral

40.

Hsueh YJ, Chen YN, Tsao YT, Cheng CM, Wu WC, Chen HC (2022) The pathomechanism, antioxidant biomarkers, and treatment of oxidative stress-related eye diseases. Int J Mol Sci 23. https://doi.org/10.3390/ijms23031255

41.

Bellezza I, Giambanco I, Minelli A, Donato R (2018) Nrf2-Keap1 signaling in oxidative and reductive stress. BBA-Mol Cell Res 1865:721–733. https://doi.org/10.1016/j.bbamcr.2018.02.010CrossRef

42.

Lu MC, Ji JA, Jiang ZY, You QD (2016) The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update. Med Res Rev 36:924–963. https://doi.org/10.1002/med.21396CrossRefPubMed

43.

Baird L, Yamamoto M (2020) The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol 40. https://doi.org/10.1128/MCB.00099-20

44.

Yamamoto M, Kensler TW, Motohashi H (2018) The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 98:1169–1203. https://doi.org/10.1152/physrev.00023.2017CrossRefPubMedPubMedCentral

45.

Peng PH, Chao HM, Juan SH, Chen CF, Liu JH, Ko ML (2011) Pharmacological preconditioning by low dose cobalt protoporphyrin induces heme oxygenase-1 overexpression and alleviates retinal ischemia-reperfusion injury in rats. Curr Eye Res 36:238–246. https://doi.org/10.3109/02713683.2010.539760CrossRefPubMed

46.

Arai-Gaun S, Katai N, Kikuchi T, Kurokawa T, Ohta K, Yoshimura N (2004) Heme oxygenase-1 induced in Müller cells plays a protective role in retinal ischemia-reperfusion injury in rats. Invest Ophthalmol Vis Sci 45:4226–4232CrossRefPubMed

47.

Sun MH, Pang JH, Chen SL, Han WH, Ho TC, Chen KJ, Kao LY, Lin KK, Tsao YP (2010) Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1. Invest Ophth Vis Sci 51:4798–4808. https://doi.org/10.1167/iovs.09-4086CrossRef

48.

Zhang X, Xu L, Chen X, Zhou X, Cao L (2022) Acacetin alleviates neuroinflammation and oxidative stress injury via the Nrf2/HO-1 pathway in a mouse model of spinal cord injury. Transl Neurosci 13:483–494. https://doi.org/10.1515/tnsci-2022-0266CrossRefPubMedPubMedCentral

49.

Zhang L, Zhang W, Zheng B, Tian N (2019) Sinomenine attenuates traumatic spinal cord injury by suppressing oxidative stress and inflammation via Nrf2 pathway. Neurochem Res 44:763–775. https://doi.org/10.1007/s11064-018-02706-zCrossRefPubMed

50.

Vahidinia Z, Khassafi N, Tameh AA, Karimian M, Zare-Dehghanani Z, Moradi F, Joghataei MT (2022) Calcitriol ameliorates brain injury in the rat model of cerebral ischemia-reperfusion through Nrf2/HO-1 signalling axis: an in silico and in vivo study. J Stroke Cerebrovasc Dis 31:106331. https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106331CrossRefPubMed

51.

Yan YF, Yang WJ, Xu Q, Chen HP, Huang XS, Qiu LY, Liao ZP, Huang QR (2015) DJ-1 upregulates anti-oxidant enzymes and attenuates hypoxia/re-oxygenation-induced oxidative stress by activation of the nuclear factor erythroid 2-like 2 signaling pathway. Mol Med Rep 12:4734–4742. https://doi.org/10.3892/mmr.2015.3947CrossRefPubMed

52.

Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP (2006) DJ-1, a cancer- and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. P Natl Acad Sci USA 103:15091–15096. https://doi.org/10.1073/pnas.0607260103CrossRef

53.

Zhang XL, Wang ZZ, Shao QH, Zhang Z, Li L, Guo ZY, Sun HM, Zhang Y, Chen NH (2019) RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3ss and JNK signaling pathways in dopaminergic neuron-like cells. Brain Res Bull 146:228–236. https://doi.org/10.1016/j.brainresbull.2019.01.007CrossRefPubMed

54.

Srivastava S, Blower PJ, Aubdool AA, Hider RC, Mann GE, Siow RC (2016) Cardioprotective effects of Cu((II))ATSM in human vascular smooth muscle cells and cardiomyocytes mediated by Nrf2 and DJ-1. Sci Rep-UK 6:7. https://doi.org/10.1038/s41598-016-0012-5CrossRef

55.

Sun Q, Shen ZY, Meng QT, Liu HZ, Duan WN, Xia ZY (2016) The role of DJ-1/Nrf2 pathway in the pathogenesis of diabetic nephropathy in rats. Ren Fail 38:294–304. https://doi.org/10.3109/0886022X.2015.1120119CrossRefPubMed

56.

Bitar MS, Liu C, Ziaei A, Chen Y, Schmedt T, Jurkunas UV (2012) Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy. Invest Ophth Vis Sci 53:5806–5813. https://doi.org/10.1167/iovs.12-10119CrossRef

57.

Liu C, Chen Y, Kochevar IE, Jurkunas UV (2014) Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV-A-induced apoptosis in corneal endothelial cells. Invest Ophth Vis Sci 55:5551–5560. https://doi.org/10.1167/iovs.14-14580CrossRef

Titel: Park7 protects retinal ganglion cells and promotes functional preservation after optic nerve crush via regulation of the Nrf2 signaling pathway
verfasst von: Lingyi Ouyang
Tao He
Yiqiao Xing
Publikationsdatum: 18.05.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 12/2023
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-023-06099-w

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Park7 protects retinal ganglion cells and promotes functional preservation after optic nerve crush via regulation of the Nrf2 signaling pathway

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2023

Comparison of the retinal microvasculature between compressive and glaucomatous optic neuropathy

Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases

Aesthetic corneal tattooing/keratopigmentation using tattoo pen machine: choosing suitable method and color

Factors affecting optical coherence tomography angiography signal strength index in patients receiving intravitreal injection treatment

Relationship between the distribution of intra-retinal hyper-reflective foci and the progression of intermediate age-related macular degeneration

Patient satisfaction after EDOF intraocular lens implantation in vitrectomized eyes

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde